Raffles Medical Group Ltd (SGX:BSL)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.8850
0.00 (0.00%)
Aug 5, 2026, 5:15 PM SGT

Raffles Medical Group Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Raffles Medical Group stock has a consensus rating of "Buy" and an average price target of $1.05. The average 1-year stock price forecast is 18.64% higher than the current stock price, while the lowest is $0.92 (+3.95%) and the highest is $1.20 (+35.59%).

Price Target: $1.05 (+18.64%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$0.92$1.05$1.09$1.20
Change+3.95%+18.64%+23.16%+35.59%

Analyst Ratings

The average analyst rating for Raffles Medical Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingOct '25Nov '25Jan '26Feb '26Mar '26Jul '26
Strong Buy344453
Buy111111
Hold211113
Sell000000
Strong Sell000000
Total666677

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Phillip Securities
Phillip Securities
Hold
Maintains
$0.92
HoldMaintains$0.92+3.95%Jul 29, 2026
CGS International
CGS International
Hold
Downgrades
$0.95
HoldDowngrades$0.95+7.34%Jul 28, 2026
DBS
DBS
Buy
Maintains
$1.25$1.20
BuyMaintains$1.25$1.20+35.59%Jul 27, 2026
UOB Kay Hian
UOB Kay Hian
Buy
Maintains
$1.25
BuyMaintains$1.25+41.24%Feb 24, 2026
Unknown Analyst
Lim & Tan Securities
No rating
Lim & Tan Securities
Buy
Maintains
$1.20
BuyMaintains$1.20+35.59%Feb 23, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
736.50M
from 765.57M
Decreased by -3.80%
Revenue Next Year
763.81M
from 736.50M
Increased by 3.71%
EPS This Year
0.03
from 0.04
Decreased by -14.33%
EPS Next Year
0.04
from 0.03
Increased by 7.70%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
725.23M824.95M708.04M752.43M765.57M736.50M
Revenue Growth
27.64%13.75%-14.17%6.27%1.75%-3.80%
Operating Income
118.20M213.26M108.19M85.10M85.97M80.95M
Net Income
84.17M143.21M90.15M62.24M70.57M63.30M
EPS
----0.040.03
EPS Growth
----18.47%-14.33%
Forward PE
45.6724.5221.3921.3625.6926.11
Dividend / Share
0.020.040.020.030.030.03
Dividend Growth
-111.11%-36.84%4.17%20.00%0.67%
Free Cash Flow
82.13M113.84M193.49M57.61M44.46M98.45M
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SGD.

Revenue Forecast

Revenue202620272028
High763.4M
Avg736.5M
Low718.1M

Revenue Growth

Revenue Growth202620272028
High
-0.3%
Avg
-3.8%
Low
-6.2%

EPS Forecast

EPS202620272028
High0.04
Avg0.03
Low0.03

EPS Growth

EPS Growth202620272028
High
1.1%
Avg
-14.3%
Low
-24.2%